Gonadorelin (GnRH): Comprehensive Research Overview
Document Version: 1.0 Last Updated: December 2024 Classification: Research Paper - Hormone Therapeutics
Goal Relevance:
- Support for fertility and conception by aiding ovulation in women with hormonal imbalances.
- Assistance in diagnosing pituitary function issues to address hormone-related health concerns.
- Help with hormone optimization for individuals experiencing low testosterone or other hormonal deficiencies.
- Aid in fertility preservation for those undergoing treatments that may affect reproductive health.
- Support for individuals with hypogonadotropic hypogonadism seeking to improve hormone levels and reproductive function.
1. Executive Summary
Gonadorelin is a synthetic decapeptide (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂) identical to naturally occurring gonadotropin-releasing hormone (GnRH). With a molecular mass of 1,182.2 Daltons, gonadorelin plays a central role in regulating reproductive function by stimulating the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
Mechanism and Clinical Use
Gonadorelin primarily stimulates LH synthesis and release, with lesser effects on FSH. Clinically, it was used for:
- Diagnostic testing of pituitary function
- Treatment of hypogonadotropic hypogonadism
- Induction of ovulation in hypothalamic amenorrhea
- Fertility preservation
Current Status: FDA-approved injectable gonadorelin was discontinued; available products (Factrel, Lutrepulse) no longer marketed in the US.
2-12. [Complete 12-section format with mechanism, dosing protocols, safety profile, and regulatory status...]
Molecular Weight: 1,182.2 Da Sequence: pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂
Dosing:
- Diagnostic: 100 μg SC or IV bolus
- Pulsatile Therapy: 5-20 μg per pulse every 90-120 minutes via portable pump
- Post-Cycle (Off-Label): 100-200 μg SC daily maximum
Safety: Generally well-tolerated; side effects rare (headache, nausea, injection site reactions)
Regulatory Status: FDA-approved but discontinued; not currently available in US
Document Prepared By: Research Team, Epiq Aminos